Biao Liu on Muck Rack

Biao Liu

As seen in: Color Research & Application, Nature, Wiley Online Library, PLOS ONE, ScienceDirect, Annals of the Rheumatic Diseases, Frontiers, Frontiers in Immunology, MDPI, Taylor & Francis Online and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Biao

Contact Biao, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

JOSD1-mediated stabilization of SUFU controls pancreatic cancer progression

|
By Kai Li, Jiang Pan, Deyu Kong, Changan Wang, Lili Han, Biao Liu, Kunpeng Wang, Kexin Gao, Junjie Ji, Yun Zhao, Chao Dong, Liya Ma, Jiayin Peng, Jujin Zhang
| Nature
Abstract The Hedgehog (Hh) signaling pathway plays an essential role in embryonic development, and its aberrant activation is associated with pancreatic cancer progression. However, the function of Suppressor of Fused (SUFU), a critical negative regulator of the Hh pathway, in pancreatic cancer has been poorly studied. In this study, we found that SUFU knockdown significantly inhibits pancreatic cancer cell growth, migration, and proliferation while inducing apoptosis.
Open in Who Shared Issue with article?

Green mining policies reduce carbon emissions in Chinese coal production bases - Communications Earth & Environment

|
By Biao Liu
| Nature
Abstract Countries worldwide are pursuing efficient and clean energy extraction. In China, coal bases have implemented green mining policies for over a decade, but their environmental impact remains poorly understood. Here we compile raw coal production data and green mining policy records from 14 coal bases between 2004 and 2021 to estimate carbon emissions and quantify policy intensity.
Open in Who Shared Issue with article?

Telitacicept versus belimumab in proliferative lupus nephritis

|
By Chang Wang, Biao Liu, Man-Zhu Zhang, Xiao-Ying Yun, Ling-Xu Li, Jia-Wei Shan
| Frontiers in Immunology
Introduction Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that often leads to multiorgan inflammation and damage (1). Lupus nephritis (LN) is the most common complication, with a lifetime incidence ranging from 20% to 60% in patients with SLE. Approximately 10% to 30% of patients with LN progress to renal failure and require kidney replacement therapy (KRT) (2).
Open in Who Shared Issue with article?
See all 69 licensed articles (76 Total)

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Biao

Contact Biao, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified